Tradewinds Capital Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-30
| Closed | -$2K | – | 785 |
|
|
2021
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 659 |
|
|
2021
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 610 |
|
|
2021
Q2 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 618 |
|
|
2018
Q4 | – | Sell |
-50
| Closed | -$3K | – | 626 |
|
|
2018
Q3 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 535 |
|
|
2016
Q4 | – | Sell |
-40
| Closed | -$2K | – | 636 |
|
|
2016
Q3 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 535 |
|
|
2015
Q2 | – | Sell |
-20
| Closed | -$2K | – | 665 |
|
|
2015
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 520 |
|
|
2014
Q4 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 574 |
|
|
2014
Q1 | – | Sell |
-120
| Closed | -$5K | – | 625 |
|
|
2013
Q4 | $5K | Buy |
+120
| New | +$5K | ﹤0.01% | 438 |
|